-
EP3946307
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3946307
| EP3946307 - SOLID NANOPARTICLE FORMULATION OF WATER INSOLUBLE PHARMACEUTICAL SUBSTANCES WITH REDUCED OSTWALD RIPENING AND IMMEDIATE DRUG RELEASE FOLLOWING INTRAVENOUS ADMINISTRATION [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 26.01.2024 Database last updated on 15.06.2024 | |
| Former | Request for examination was made Status updated on 07.01.2022 | ||
| Former | The international publication has been made Status updated on 09.10.2020 | Most recent event Tooltip | 05.06.2024 | New entry: Additional fee for renewal fee: despatch of communication + time limit | Applicant(s) | For all designated states Selvaraj, Ulagaraj 130 W Rhapsody Drive San Antonio TX 78216 / US | For all designated states Woody, David L. 130 W Rhapsody Drive San Antonio TX 78216 / US | For all designated states Boatright, John, H. 130 W Rhapsody Drive San Antonio TX 78216 / US | For all designated states Wen, Dong 130 W Rhapsody Drive San Antonio TX 78216 / US | [2022/06] | Inventor(s) | 01 /
see applicant ... | [2022/06] | Representative(s) | Freyria Fava, Cristina Buzzi, Notaro & Antonielli d'Oulx S.p.A. Corso Vittorio Emanuele ll, 6 10123 Torino / IT | [2022/06] | Application number, filing date | 20784502.5 | 02.04.2020 | [2022/06] | WO2020US26402 | Priority number, date | US201962828292P | 02.04.2019 Original published format: US 201962828292 P | [2022/06] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020206132 | Date: | 08.10.2020 | Language: | EN | [2020/41] | Type: | A1 Application with search report | No.: | EP3946307 | Date: | 09.02.2022 | Language: | EN | The application published by WIPO in one of the EPO official languages on 08.10.2020 takes the place of the publication of the European patent application. | [2022/06] | Search report(s) | International search report - published on: | US | 08.10.2020 | (Supplementary) European search report - dispatched on: | EP | 16.11.2022 | Classification | IPC: | A61K31/20, A61K31/337, A61K31/427, A61K9/127, A61K9/51, A61K9/19 | [2022/50] | CPC: |
A61K9/0019 (EP);
A61K9/1694 (US);
A61K31/05 (EP);
A61K31/337 (EP,US);
A61K31/357 (US);
A61K31/395 (US);
A61K31/427 (EP,US);
A61K31/436 (EP,US);
A61K31/496 (EP,US);
A61K9/10 (EP);
A61K9/1272 (EP);
A61K9/1658 (US);
| C-Set: |
A61K31/05, A61K2300/00 (EP);
A61K31/337, A61K2300/00 (EP);
A61K31/427, A61K2300/00 (EP);
A61K31/436, A61K2300/00 (EP); |
| Former IPC [2022/06] | A61K31/20, A61K31/337, A61K31/427 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/06] | Title | German: | FESTE NANOPARTIKELFORMULIERUNG VON WASSERUNLÖSLICHEN PHARMAZEUTISCHEN SUBSTANZEN MIT VERMINDERTER OSTWALD-REIFUNG UND SOFORTIGER ARZNEIMITTELFREISETZUNG NACH INTRAVENÖSER VERABREICHUNG | [2022/06] | English: | SOLID NANOPARTICLE FORMULATION OF WATER INSOLUBLE PHARMACEUTICAL SUBSTANCES WITH REDUCED OSTWALD RIPENING AND IMMEDIATE DRUG RELEASE FOLLOWING INTRAVENOUS ADMINISTRATION | [2022/06] | French: | FORMULATION DE NANOPARTICULES SOLIDES DE SUBSTANCES PHARMACEUTIQUES INSOLUBLES DANS L'EAU AVEC MÛRISSEMENT D'OSTWALD RÉDUIT ET LIBÉRATION IMMÉDIATE DE MÉDICAMENT APRÈS ADMINISTRATION INTRAVEINEUSE | [2022/06] | Entry into regional phase | 02.11.2021 | National basic fee paid | 02.11.2021 | Search fee paid | 02.11.2021 | Designation fee(s) paid | 02.11.2021 | Examination fee paid | Examination procedure | 02.11.2021 | Examination requested [2022/06] | 16.06.2023 | Amendment by applicant (claims and/or description) | 30.01.2024 | Despatch of a communication from the examining division (Time limit: M06) | Fees paid | Renewal fee | 29.04.2022 | Renewal fee patent year 03 | 02.05.2023 | Renewal fee patent year 04 | Penalty fee | Additional fee for renewal fee | 30.04.2024 | 05 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]US6749868 (DESAI NEIL P [US], et al) [X] 1-15 * the whole document * * examples 1-25; claims 1-21 *; | [X]WO2017044936 (PFIZER [US]) [X] 1-15 * the whole document * * figure 1; claims 1-14 *; | [X]WO2019055525 (SELVARAJ RAJ [US], et al) [X] 1-15 * the whole document ** examples 1-11; claims 1-31 * | International search | [XY]US2009238878 (SINGH CHANDRA ULAGARAJ [US]) [X] 1-2, 6, 11-14, 18-26 * Abstract, para [0046], [0061], [0063], [0067], [0069], [0072], [0073], [0093], [0126], [0130], [0133]-[0135], [0146]-[0149] * [Y] 3-5, 7-9; | [Y]US2013059018 (PAROLARO DANIELA [IT], et al) [Y] 5 * Abstract *; | [A]US2016367514 (SINGH CHANDRA ULAGARAJ [US]) [A] 1-9, 11-14, 18-26 * entire document *; | [Y]US2017135971 (WANEBO HAROLD J [US]) [Y] 3-4, 7-9 * Abstract, para [0051], [0153], TABLE 1 *; | [A]US2018250646 (MAGDASSI SHLOMO [IL], et al) [A] 1-9, 11-14, 18-26* entire document * |